CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma()

por Yang, Yu-Feng, Pan, Ying-Hua, Tian, Qiu-Hong, Wu, Dan-Chun, Su, Shu-Guang
Publicado 2018

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()

por Fu, Jia, Li, Min, Wu, Dan-Chun, Liu, Li-Li, Chen, Shi-Lu, Yun, Jing-Ping
Publicado 2015

HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma

por Wu, Dan-Chun, Zhang, Mei-Fang, Su, Shu-Guang, Fang, Heng-Ying, Wang, Xue-Hua, He, Dan, Xie, Yuan-Yuan, Liu, Xu-Hui
Publicado 2016